FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 62 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,169,350 | -29.8% | 433,870 | -1.2% | 0.00% | – |
| Q2 2023 | $3,092,440 | +21.8% | 439,267 | +7.3% | 0.00% | – |
| Q1 2023 | $2,538,981 | -50.8% | 409,513 | -49.3% | 0.00% | – |
| Q4 2022 | $5,156,800 | +61.8% | 808,276 | +117.5% | 0.00% | – |
| Q3 2022 | $3,188,000 | -36.6% | 371,618 | +0.4% | 0.00% | – |
| Q2 2022 | $5,032,000 | +3.8% | 370,032 | +16.3% | 0.00% | – |
| Q1 2022 | $4,847,000 | -30.0% | 318,225 | +5.2% | 0.00% | – |
| Q4 2021 | $6,920,000 | +120.7% | 302,574 | +34.5% | 0.00% | – |
| Q3 2021 | $3,135,000 | +55.1% | 225,020 | +18.8% | 0.00% | – |
| Q2 2021 | $2,021,000 | +40.5% | 189,399 | +73.6% | 0.00% | – |
| Q1 2021 | $1,438,000 | -30.3% | 109,099 | +7.2% | 0.00% | – |
| Q4 2020 | $2,063,000 | – | 101,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $16,623,000 | 5.56% |
| Flagship Pioneering Inc. | 12,674,120 | $167,045,000 | 2.68% |
| Birchview Capital, LP | 314,143 | $4,140,000 | 2.46% |
| Monashee Investment Management LLC | 530,581 | $6,993,000 | 1.08% |
| Artal Group S.A. | 1,720,720 | $22,679,000 | 0.40% |
| Octagon Capital Advisors LP | 69,132 | $911,000 | 0.34% |
| Cormorant Asset Management, LP | 1,000,000 | $13,180,000 | 0.29% |
| Alphabet Inc. | 500,901 | $6,602,000 | 0.27% |
| Casdin Capital, LLC | 216,216 | $2,850,000 | 0.08% |
| Board of Trustees of The Leland Stanford Junior University | 30,657 | $404,000 | 0.04% |